Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease Patrick J. Geraghty, MD, Mark W. Mewissen, MD, Michael R. Jaff, DO, Gary M. Ansel, MD Journal of Vascular Surgery Volume 58, Issue 2, Pages 386-395.e4 (August 2013) DOI: 10.1016/j.jvs.2013.01.050 Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 1 Primary patency (peak systolic velocity ratio [PSVR] ≤ 2.0). Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 2 Primary-assisted patency. Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 3 Secondary patency. Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 6 Freedom from first reintervention. Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 4 (online only) Primary patency using alternate criterion of peak systolic velocity ratio (PSVR) ≤ 2.5. Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 5 (online only) Primary patency using alternate criterion of peak systolic velocity ratio (PSVR) ≤ 3.0. Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions